Glyreg Liquid
NDC Package 43742-1931-1
Package Information
Glyreg (aceticum acidum, cacao, magnesia sulphurica, natrum sulphuricum, verbascum thapsus, glandula suprarenalis suis, pancreas suis, cortisone aceticum, thyroidinum (suis), iodium, lycopodium clavatum, phosphorus, ranunculus bulbosus, saccharum officinale, vanadium metallicum, zincum metallicum, chromium acidum, culex musca) liquids is for temporary relief of symptoms related to fluctuations in blood sugar or dietary patterns low in carbohydrates, including hunger, dizziness, brain fog, shakiness, fatigue, cravings and irritability.****These statements are based upon homeopathic principles. This formulation utilizes a liquid delivery system. Marketed by Deseret Biologicals, Inc, this product is identified by NDC 43742-1931.
Identification & Billing
Clinical Specifications
- ACETIC ACID 3 [hp_X]/mL
- CHROMIUM TRIOXIDE 16 [hp_X]/mL
- COCOA 6 [hp_X]/mL
- CORTISONE ACETATE 8 [hp_X]/mL
- CULEX PIPIENS 16 [hp_X]/mL
- IODINE 12 [hp_X]/mL
- LYCOPODIUM CLAVATUM SPORE 12 [hp_X]/mL
- MAGNESIUM SULFATE HEPTAHYDRATE 6 [hp_X]/mL
- PHOSPHORUS 12 [hp_X]/mL
- RANUNCULUS BULBOSUS WHOLE 12 [hp_X]/mL
- SODIUM SULFATE 6 [hp_X]/mL
- SUCROSE 12 [hp_X]/mL
- SUS SCROFA ADRENAL GLAND 8 [hp_X]/mL
- SUS SCROFA PANCREAS 8 [hp_X]/mL
- THYROID 8 [hp_X]/mL
- VANADIUM 12 [hp_X]/mL
- VERBASCUM THAPSUS WHOLE 6 [hp_X]/mL
- ZINC 12 [hp_X]/mL
- Allergens - [CS]
- Calculi Dissolution Agent - [EPC] (Established Pharmacologic Class)
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Corticosteroid Hormone Receptor Agonists - [MoA] (Mechanism of Action)
- Corticosteroid - [EPC] (Established Pharmacologic Class)
- Dietary Proteins - [CS]
- Increased Histamine Release - [PE] (Physiologic Effect)
- Increased Large Intestinal Motility - [PE] (Physiologic Effect)
- Inhibition Large Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Inhibition Small Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Magnesium Ion Exchange Activity - [MoA] (Mechanism of Action)
- Non-Standardized Food Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Osmotic Activity - [MoA] (Mechanism of Action)
- Osmotic Laxative - [EPC] (Established Pharmacologic Class)
- Plant Proteins - [CS]
- Stimulation Large Intestine Fluid/Electrolyte Secretion - [PE] (Physiologic Effect)
Regulatory & Marketing
Hierarchy Structure
- 43742 - Deseret Biologicals, Inc
- 43742-1931 - Glyreg
- 43742-1931-1 - 30 mL in 1 BOTTLE, DROPPER
- 43742-1931 - Glyreg
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 43742-1931-1 identifies a specific commercial package of 30 ml in 1 bottle, dropper of Glyreg, a human over the counter drug labeled by Deseret Biologicals, Inc. This liquid is formulated for oral use and contains acetic acid; chromium trioxide; cocoa; cortisone acetate; culex pipiens; iodine; lycopodium clavatum spore; magnesium sulfate heptahydrate; phosphorus; ranunculus bulbosus whole; sodium sulfate; sucrose; sus scrofa adrenal gland; sus scrofa pancreas; thyroid; vanadium; verbascum thapsus whole; zinc as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Deseret Biologicals, Inc on October 26, 2020. The current certification is valid through December 31, 2026.
How is this Deseret Biologicals, Inc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 43742193101. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.